Beat The Denominator

MicroStrategy (MSTR) has become more attractive after successfully raising cash to cover its upcoming dividend, removing a significant short-term risk for the stock. This operational strength solidifies MSTR as a compelling way to gain leveraged exposure to Bitcoin. For those holding the company's preferred shares, such as STRK and Stride, the dividend payment is now secured for September 30th. However, be aware of a potential price drop in these preferred shares immediately after the dividend is paid. Ultimately, Bitcoin (BTC) is framed as a core long-term holding for investors who can look past short-term price movements.

The speaker is long-term bullish on Bitcoin (BTC), viewing the current market fear and price consolidation as a buying opportunity before a significant future rally. For a leveraged bet on Bitcoin, consider MicroStrategy (MSTR), a company that continuously accumulates BTC on its balance sheet. The most compelling opportunity mentioned is the MicroStrategy preferred security "Strike", which offers a high 9.1% yield. Strike combines this income with significant growth potential through an embedded call option that activates if MSTR stock reaches $1,000. For investors prioritizing stable, monthly income over growth, the "Stretch" preferred security offers a 10% yield and is designed to trade around $100.

CoreMedics (CRMD) is presented as a high-conviction med-tech play with the potential for a 20x return as it begins its commercial product rollout. With its stock down approximately 40% from its highs, energy drink leader Celsius (CELH) is viewed as a timely buying opportunity in a high-growth category winner. For real estate exposure, consider **

Consider Hims & Hers Health (HIMS) as a growth investment due to its strong marketing and a significant upcoming catalyst with its menopause product launch. For a specific yield opportunity, the MicroStrategy security "Stretch" is designed to move from its current $97 price towards $99 through a built-in dividend incentive. View MicroStrategy (MSTR) as a core long-term holding and a leveraged way to gain exposure to Bitcoin, valuing it on its growing crypto treasury rather than daily price swings. Investors should avoid panic selling MSTR on dips, as its fundamental value is tied to its Bitcoin accumulation. The underlying thesis suggests accumulating Bitcoin (BTC) itself as a long-term hedge against currency debasement, viewing recent price drops as temporary.

Consider UPEXI as a compelling way to invest in the Solana (SOL) ecosystem, as the stock is trading at a 23% discount to the value of its underlying digital assets. Furthermore, the company generates an 8% yield by staking its SOL holdings, creating a consistent profit stream. For investors bullish on Bitcoin, MicroStrategy (MSTR) is presented as a long-term buying opportunity due to its historically low premium over its large Bitcoin treasury. A new all-time high in Bitcoin is viewed as the primary catalyst that would fuel a significant price increase in MSTR. Investors should be prepared for high volatility in these hyper-growth names, as large gains may require holding through frustrating periods.

A merger arbitrage opportunity exists with Semler Scientific (SMLR), which is being acquired by Strive Asset Management (ASST) at a significant premium. Investors bullish on ASST can consider buying SMLR to acquire the acquirer's stock at a potential discount, as SMLR trades for less than the value of its Bitcoin holdings. This trade is a bet that the high valuation of ASST will hold steady through the merger's completion. For a more straightforward investment in the Bitcoin treasury space, consider MicroStrategy (MSTR). MSTR is highlighted as the highest-quality, "blue-chip" alternative for gaining leveraged exposure to Bitcoin.

Key AI stocks like Nvidia (NVDA) and Tesla (TSLA) are considered significantly undervalued, presenting a potential long-term investment opportunity. This view is based on the belief that the market has not fully priced in the transformative impact of the Artificial Intelligence revolution. Similarly, the recent price drop in Bitcoin (BTC) is viewed as an irrational, hype-driven event rather than a fundamental problem. This could represent a buying opportunity for investors who believe in its long-term value. Investors are advised to be cautious of social media hype and focus on the fundamental value of their assets.

Consider investing in Marathon Digital (MARA), as it is flagged as a potential acquisition target due to its low valuation relative to its Bitcoin assets. This thesis is supported by the recent acquisition of Semler Scientific (SMLR) at a 210% premium, setting a precedent for undervalued Bitcoin-holding companies. For investors seeking leveraged Bitcoin exposure, MicroStrategy (MSTR) shows strong bullish signals as investor demand remains high despite new share issuance. A broader strategy is to identify other Bitcoin treasury companies trading at a discount to the value of their crypto holdings. Lastly, traders should be aware of a recurring pattern where Bitcoin (BTC) prices often dip on Sunday nights and Monday mornings, potentially offering better entry points.

MicroStrategy (MSTR) is presented as a leveraged investment in Bitcoin, recently outperforming direct spot ETFs like IBIT. The company's value is enhanced by its ability to issue new stock at a premium to its underlying Bitcoin holdings. For investors seeking a blend of income and growth, the "Strife" preferred instrument offers a steady yield and is convertible into MSTR common stock. Alternatively, the "Stride" preferred instrument targets high-yield investors with a potential 13% return, though it carries higher risk as dividend payments can be skipped. This makes MSTR and its related securities a way to gain amplified exposure to Bitcoin with options for different risk appetites.

Despite recent price drops, high-growth stocks like Duolingo (DUOL), CAVA Group (CAVA), and Lululemon (LULU) are still considered overvalued and should be avoided. Duolingo is unattractive due to its high valuation and the significant long-term competitive threat from AI in language learning. While CAVA is a strong business, its stock is too expensive, and investors should wait for a major price correction before considering a position. Lululemon faces slowing growth and intense competition, making it a "fallen hyper-growth stock" to steer clear of even after its 50% decline. The primary takeaway is to exercise caution, as the current valuations for these companies do not justify their underlying risks.

Consider MicroStrategy (MSTR) as the premier, "blue chip" stock for gaining exposure to Bitcoin, with a core strategy of holding shares in anticipation of a "fall rally". A key near-term catalyst to watch is MSTR's "Stretch" preferred stock; a price move above $99 would be a very bullish signal for the company's capital-raising ability. Investors should also monitor the company's 8-K filings to track the success of its ongoing preferred stock offerings. In contrast, it is advised to avoid smaller, highly volatile competitors like Nakamoto (Naka) due to their demonstrated extreme downside risk. The overall thesis is to remain patient with this long-term holding, similar to how early investors held Tesla (TSLA) through periods of stagnation.

Investors should monitor Bitcoin (BTC), as a break above its all-time high is expected to be a major catalyst for a rally towards a potential $125,000 milestone. For leveraged exposure, consider MicroStrategy (MSTR), which has a history of outperforming Bitcoin over the long term by using its stock to fund BTC purchases. The stock's recent underperformance relative to BTC may present a buying opportunity for patient, long-term investors. A more speculative, high-conviction trade is the MicroStrategy preferred stock, which is projected to reach $100. However, investors should wait for trading volume to increase on this new instrument before considering a position.

Consider the recent sell-off in Celsius Holdings (CELH) a buying opportunity, as its acquisition of Alani strengthens its market position. LifeMD (LFMD) is presented as an undervalued telehealth play, trading at a significant discount to its competitor Hims (HIMS). The recent price drop in CorMedix (CRMD) is seen as a market overreaction, creating an attractive entry point for its money-saving medical product, Defencaf. For a contrarian investment in real estate, The Real Brokerage (REAX) is rapidly gaining market share and is considered cheaply valued. These opportunities focus on high-growth companies and deep value situations that appear to be currently mispriced by the market.

MicroStrategy (MSTR) is presented as a long-term buying opportunity, currently in a "valley of despair" but viewed as a "coiled spring" for future gains. The core investment thesis relies on its strategy of issuing stock at a premium to its Bitcoin holdings and using the proceeds to acquire more Bitcoin. This process aims to increase the amount of Bitcoin per share, with a revised target of achieving a 30% Bitcoin yield for investors in 2025. The stock currently trades at a 1.43x premium to the value of its Bitcoin, a key metric for this strategy's success. Ultimately, an investment in MSTR is a leveraged bet for those who are fundamentally bullish on the long-term price of Bitcoin.

A new bull market may be starting, driven by expected interest rate cuts that favor growth stocks. The highest conviction idea is MicroStrategy (MSTR), which is seen as a leveraged play on Bitcoin and is potentially forming a bottom before its next move higher. Another key opportunity is Tesla (TSLA), with its recent approval for self-driving operations in Nevada acting as a major positive catalyst. To gain broader exposure to market confidence, consider the Renaissance IPO ETF (IPO), which tracks the performance of recent public offerings. The ARK Next Generation Internet ETF (ARKW) is also trading near its all-time high, signaling strong investor appetite for disruptive technology stocks.

Hims & Hers Health (HIMS) has launched a new Testosterone Replacement Therapy (TRT) service, which is a major growth catalyst for the company. This new product creates a significant cross-selling opportunity to its large existing customer base and disrupts traditional healthcare with a subscription model that is cheaper than most insurance co-pays. The stock is considered undervalued, with analysis suggesting a potential 3.5x increase in its valuation multiple over the long term. Due to its price volatility, HIMS is best suited as a long-term investment. For those interested in the telehealth sector, competitor LifeMD (LFMD) is also viewed as inexpensive but is considered a lower-quality alternative to HIMS.